MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints ...Middle East

PR Newswire - News
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker MARLBOROUGH, Mass., May 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive six-month...

Hence then, the article about modular atp study of the mcrm system meets primary safety and efficacy endpoints was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints )

Apple Storegoogle play

Last updated :

Also on site :



Latest News